FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395892000: Sumatriptan (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469832013 Sumatriptan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489528019 Sumatriptan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54671000195119 sumatriptan it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
843211000172115 sumatriptan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69041000195111 Sumatriptan de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sumatriptan (substance) Is a vasoconstricteur false Inferred relationship Some
Sumatriptan (substance) Is a Sulfonamide (substance) true Inferred relationship Some
Sumatriptan (substance) Is a Serotonin 5-HT1 receptor agonist true Inferred relationship Some
Sumatriptan (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
sumatriptan 12 mg/mL, seringue préremplie de 0,5 mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Product containing sumatriptan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Sumatriptan 20mg nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 5mg nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan succinate 25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 10mg nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan succinate Is a False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 100mg rapid relase tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 50mg rapid release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Sumatriptan 6mg/0.5mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 4mg injection solution prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan 6mg injection solution prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Product containing naproxen sodium and sumatriptan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan (substance) Inferred relationship Some
Sumatriptan-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan (substance) Inferred relationship Some 1
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan (substance) Inferred relationship Some 1
Product containing naproxen and sumatriptan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 2
Naproxen- and sumatriptan-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 2
Sumatriptan succinate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sumatriptan (substance) Inferred relationship Some
Product containing only naproxen and sumatriptan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 2
Sumatriptan only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Naproxen and sumatriptan only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 2
Product containing only sumatriptan in nasal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Product containing only sumatriptan in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Product containing only sumatriptan in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan (substance) Inferred relationship Some 1
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan (substance) Inferred relationship Some 1
Sumatriptan hemisulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sumatriptan (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start